Extending the dosing range for simvastatin: The efficacy and safety of Simvastatin 80 mg/d

被引：0
|
作者：
Ose, L [1 ]
Corsetti, LA [1 ]
Tate, AC [1 ]
Shahane, A [1 ]
Mitchel, YB [1 ]
机构：
[1] MERCK RES LABS,RAHWAY,NJ
来源：
ATHEROSCLEROSIS | 1997年 / 134卷 / 1-2期
关键词：
D O I：
10.1016/S0021-9150(97)88706-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：131 / 131
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of Simvastatin 80 mg/day in hypercholesterolemic patients
    Stein, EA
    Davidson, MH
    Dobs, AS
    Schrott, H
    Dujovne, CA
    Bays, H
    Weiss, SR
    Melino, MR
    Stepanavage, ME
    Mitchel, YB
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1998, 82 (03): : 311 - 316
  • [2] Targeting high risk patients with hypercholesterolemia: The efficacy and safety of simvastatin 80 mg/d
    Hunninghake, DB
    [J]. ATHEROSCLEROSIS, 1997, 134 (1-2) : 125 - 126
  • [3] Expanded doses of simvastatin; Efficacy and safety of 80 and 160 mg in hypercholesterolemia
    Weiss, SR
    Knopp, R
    Davidson, M
    Stein, EA
    Laskarzewski, P
    Illingworth, DR
    Dujovne, C
    Hunninghake, D
    Melino, MR
    Mitchel, YB
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (02) : 8064 - 8064
  • [4] The efficacy and safety of simvastatin 80 mg; Pooled results from worldwide clinical studies
    Davidson, MH
    Stein, EA
    Hunninghake, D
    Ose, L
    Dujovne, C
    Insull, W
    Bertolami, M
    Weiss, S
    Pasternak, S
    Conroy, B
    Corsetti, L
    O'Grady, L
    Kush, D
    Plotkin, D
    Tate, A
    Melino, MR
    Stepanavage, M
    Mercuri, M
    Mitchel, YB
    [J]. ATHEROSCLEROSIS, 1999, 144 : 30 - 30
  • [5] Efficacy and six-month safety of simvastatin 80 mg/day: Results from the worldwide simvastatin expanded dose program (WSEDP)
    Ose, L
    Kastelein, JJP
    Scott, R
    Stein, EA
    Campodonico, S
    Escobar, ID
    Tate, AC
    Corsetti, L
    Shahane, A
    Mitchel, YB
    Mercuri, M
    [J]. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 1998, 8 (03) : 135 - 143
  • [6] The Dutch express FH genetic substudy: Efficacy and safety of simvastatin 80 mg in familial hypercholesterolemia (FH)
    Nolting, PRWD
    Trip, MD
    Kastelein, JJP
    [J]. ATHEROSCLEROSIS, 1999, 144 : 26 - 26
  • [7] Comparison of the efficacy and safety of a combination tablet of niacin extended-release and simvastatin with simvastatin 80 mg monotherapy: the SEACOAST II (high-dose) study
    Ballantyne, Christie M.
    Davidson, Michael H.
    McKenney, James M.
    Keller, Laurence H.
    Bajorunas, Daiva R.
    Karas, Richard H.
    [J]. JOURNAL OF CLINICAL LIPIDOLOGY, 2008, 2 (02) : 79 - 90
  • [8] The efficacy and six-week tolerability of Simvastatin 80 and 160 mg/day
    Davidson, MH
    Stein, EA
    Dujovne, CA
    Hunninghake, DB
    Weiss, SR
    Knopp, RH
    Illingworth, DR
    Mitchel, YB
    Melino, MR
    Zupkis, RV
    Dobrinska, MR
    Amin, RD
    Tobert, JA
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1997, 79 (01): : 38 - 42
  • [9] Comparison of efficacy and safety of atorvastatin (10 mg) with simvastatin (10 mg) at six weeks
    Insull, W
    Kafonek, S
    Goldner, D
    Zieve, F
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2001, 87 (05): : 554 - 559
  • [10] EFFICACY AND SAFETY OF SIMVASTATIN IN PRIMARY HYPERCHOLESTEROLEMIA
    YOMTOV, B
    CHATENETDUCHENE, L
    [J]. SEMAINE DES HOPITAUX, 1995, 71 (7-8): : 249 - 254
12345